Cover Image

Evidence-based management of COVID-19 in cancer patients: guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

Since its first detection in China in late 2019 the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious disease COVID-19 continue to have a major impact on global healthcare and clinical practice. Cancer patients, in particular those with haematological m...

Full description

Saved in:
Bibliographic Details
Main Authors: Giesen, Nicola (Author) , Sprute, Rosanne (Author) , Rüthrich, Maria Madeleine (Author) , Khodamoradi, Yascha (Author) , Mellinghoff, Sibylle Christiane (Author) , Beutel, Gernot (Author) , Lück, Catherina (Author) , Koldehoff, Michael (Author) , Hentrich, Marcus (Author) , Sandherr, Michael (Author) , Bergwelt, Michael von (Author) , Wolf, Hans-Heinrich (Author) , Hirsch, Hans H. (Author) , Wörmann, Bernhard (Author) , Cornely, Oliver Andreas (Author) , Köhler, Philipp (Author) , Schalk, Enrico (Author) , Lilienfeld-Toal, Marie von (Author)
Format: Article (Journal)
Language:English
Published: 21 September 2020
In: European journal of cancer
Year: 2020, Volume: 140, Pages: 86-104
ISSN:1879-0852
DOI:10.1016/j.ejca.2020.09.009
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejca.2020.09.009
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0959804920304937
Get full text
Author Notes:Nicola Giesen, Rosanne Sprute, Maria Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, Catherina Lueck, Michael Koldehoff, Marcus Hentrich, Michael Sandherr, Michael von Bergwelt-Baildon, Hans-Heinrich Wolf, Hans H. Hirsch, Bernhard Wörmann, Oliver A. Cornely, Philipp Köhler, Enrico Schalk, Marie von Lilienfeld-Toal
Description
Summary:Since its first detection in China in late 2019 the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious disease COVID-19 continue to have a major impact on global healthcare and clinical practice. Cancer patients, in particular those with haematological malignancies, seem to be at an increased risk for a severe course of infection. Deliberations to avoid or defer potentially immunosuppressive therapies in these patients need to be balanced against the overarching goal of providing optimal antineoplastic treatment. This poses a unique challenge to treating physicians. This guideline provides evidence-based recommendations regarding prevention, diagnostics and treatment of SARS-CoV-2 infection and COVID-19 as well as strategies towards safe antineoplastic care during the COVID-19 pandemic. It was prepared by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) by critically reviewing the currently available data on SARS-CoV-2 and COVID-19 in cancer patients applying evidence-based medicine criteria.
Item Description:Gesehen am 21.01.2020
Physical Description:Online Resource
ISSN:1879-0852
DOI:10.1016/j.ejca.2020.09.009

Similar Items